IP Verse

Roth, Carla opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Roth, Carla

Patent Number:
EP3631454
Title:
Treatment Of Lag-3 Positive Tumors
Applicant:
BRISTOL-MYERS SQUIBB COMPANY
Opposition Date:
Jun 3, 2024
Patent Number:
EP3334747
Title:
Charged Depth Filtration Of Antigen-Binding Proteins
Applicant:
AMGEN INC.
Opposition Date:
Sep 28, 2023
Patent Number:
EP3443124
Title:
Methods And Systems For Amplification In Complex Samples
Applicant:
T2 BIOSYSTEMS, INC.
Opposition Date:
May 17, 2023
Patent Number:
EP3218406
Title:
Binding Molecules Specific For Cd73 And Uses Thereof
Applicant:
MEDIMMUNE LIMITED
Opposition Date:
Dec 23, 2021
Patent Number:
EP2766040
Title:
Uses For And Article Of Manufacture Including Her2 Dimerization Inhibitor Pertuzumab
Applicant:
F. HOFFMANN-LA ROCHE AG
Opposition Date:
Feb 14, 2020

Competitors of Roth, Carla

AMGEN INC.

BRISTOL-MYERS SQUIBB COMPANY

F. HOFFMANN-LA ROCHE AG

Want to track Roth, Carla?

Feel free to send us a message here and we will get back to you